Skip to main content
Clinical Trials/IRCT201701172709N44
IRCT201701172709N44
Completed
Phase 3

The effect of hydro-alcoholic extract of Portulaca Oleracea L. (purslane) on Liver enzymes, Glycemic status and lipid profile in non-alcoholic fatty liver disease: a randomized, double-blind clinical trial.

Iran University of Medical Sciences0 sites74 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
onalcoholic fatty liver disease.
Sponsor
Iran University of Medical Sciences
Enrollment
74
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Being volunteer or Wishing to attend
  • Age 18 years or older
  • Alanine aminotransferase (ALT) greater than 19 IU/L for women and greater than 30 IU/L for men
  • Evidence of fatty liver in ultrasonography with a score of 1 or more
  • BMI: 20\-40 kg/m2

Exclusion Criteria

  • Other acute or chronic hepatic disorders (hepatitis B or C)
  • Biliary diseases
  • Hypertension
  • History of cardiovascular disease
  • Nephrolithiasis (oxalate stones) or history of oxalate stones
  • Consumption of omega\-3 and vitamin E supplement
  • Alcohol use
  • Use of hepatotoxic medications during last month
  • Changing medication dosage during the study
  • Compliacne less than 80%

Outcomes

Primary Outcomes

Not specified

Similar Trials